Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Revenue Summary of Blau Farmacêutica S.A.

Blau Farmacêutica S.A.'s latest annual revenue in 2023 was 1.37 Billion BRL , down -2.44% from previous year.
Blau Farmacêutica S.A.'s latest quarterly revenue in 2024 Q2 was 465.1 Million BRL , up 29.31% from previous quarter.
Blau Farmacêutica S.A. reported a annual revenue of 1.4 Billion BRL in annual revenue 2022, up 2.96% from previous year.
Blau Farmacêutica S.A. reported a annual revenue of 1.36 Billion BRL in annual revenue 2021, up 15.62% from previous year.
Blau Farmacêutica S.A. reported a quarterly revenue of 359.68 Million BRL for 2024 Q1, down -7.17% from previous quarter.
Blau Farmacêutica S.A. reported a quarterly revenue of 362.64 Million BRL for 2023 Q3, down -0.46% from previous quarter.

Annual Revenue Chart of Blau Farmacêutica S.A. (2023 - 2015)

Historical Annual Revenue of Blau Farmacêutica S.A. (2023 - 2015)

Year	Revenue	Revenue Growth
2023	1.37 Billion BRL	-2.44%
2022	1.4 Billion BRL	2.96%
2021	1.36 Billion BRL	15.62%
2020	1.18 Billion BRL	20.9%
2019	977.5 Million BRL	24.97%
2018	782.16 Million BRL	26.63%
2017	617.65 Million BRL	43.33%
2016	430.93 Million BRL	12.38%
2015	383.45 Million BRL	0.0%

Year	Revenue	Revenue Growth
2024 Q2	465.1 Million BRL	29.31%
2024 Q1	359.68 Million BRL	-7.17%
2023 Q3	362.64 Million BRL	-0.46%
2023 Q1	258.2 Million BRL	-29.59%
2023 Q2	364.3 Million BRL	41.1%
2023 Q4	387.47 Million BRL	6.85%
2023 FY	1.37 Billion BRL	-2.44%
2022 FY	1.4 Billion BRL	2.96%
2022 Q4	366.69 Million BRL	1.4%
2022 Q3	361.63 Million BRL	-0.99%
2022 Q2	365.23 Million BRL	16.56%
2022 Q1	313.34 Million BRL	-10.45%
2021 Q4	349.89 Million BRL	9.47%
2021 Q1	326.12 Million BRL	-3.46%
2021 Q3	319.62 Million BRL	-13.79%
2021 Q2	370.76 Million BRL	13.69%
2021 FY	1.36 Billion BRL	15.62%
2020 Q2	322.12 Million BRL	47.07%
2020 FY	1.18 Billion BRL	20.9%
2020 Q4	337.83 Million BRL	11.56%
2020 Q3	302.82 Million BRL	-5.99%
2020 Q1	219.03 Million BRL	-1.44%
2019 Q3	265.26 Million BRL	-12.07%
2019 Q2	301.69 Million BRL	60.21%
2019 Q1	188.3 Million BRL	-18.6%
2019 FY	977.5 Million BRL	24.97%
2019 Q4	222.23 Million BRL	-16.22%
2018 Q2	182.24 Million BRL	19.96%
2018 FY	782.16 Million BRL	26.63%
2018 Q4	231.32 Million BRL	6.77%
2018 Q3	216.66 Million BRL	18.89%
2018 Q1	151.92 Million BRL	0.0%
2017 FY	617.65 Million BRL	43.33%
2016 FY	430.93 Million BRL	12.38%
2015 FY	383.45 Million BRL	0.0%

Peer Revenue Comparison of Blau Farmacêutica S.A.

Name	Revenue	Revenue Difference
Hypera S.A.	7.91 Billion BRL	82.657%